Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | Yes |
| Is net profit margin increasing? | No | Yes |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | No | No |
| Competitors Used |
|---|
| Revvity, Inc. |
| Bio-Techne Corporation |
| Agilent Technologies, Inc. |
| Thermo Fisher Scientific Inc. |
| Mesa Laboratories, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| RVTY | TECH | A | TMO | MLAB | DAP | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 4% | 7% | 21% | 14% | -89% | 7% | ||
| Fiscal Year - 1 | 2% | 16% | 22% | 13% | 0% | 8% | ||
| Fiscal Year - 2 | 7% | 17% | 23% | 16% | 0% | 14% | ||
| Fiscal Year - 3 | 16% | 10% | 24% | 21% | 1% | 13% | ||
| Fiscal Year - 4 | 19% | 18% | 15% | 20% | 1% | 11% | ||
| Fiscal Year - 5 | 8% | 9% | 23% | 13% | 7% | 8% | ||
| Average | 10% | 12% | 21% | 16% | -13% | 10% | ||
| Median | 8% | 13% | 23% | 15% | 1% | 10% | ||
| Benchmarks | Ticker | |||||||
| Revvity, Inc. | NYSE:RVTY | |||||||
| Bio-Techne Corporation | NasdaqGS:TECH | |||||||
| Agilent Technologies, Inc. | NYSE:A | |||||||
| Thermo Fisher Scientific Inc. | NYSE:TMO | |||||||
| Mesa Laboratories, Inc. | NasdaqGS:MLAB | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | RVTY | TECH | A | TMO | MLAB | DAP | ||
| Latest Fiscal Year | Dec-24 | Jun-24 | Oct-24 | Dec-24 | Mar-24 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Jan-25 | Mar-25 | Dec-24 | Mar-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 2,770 | 1,209 | 6,533 | 42,898 | 238 | 23,820 | ||
| Fiscal Year | 2,755 | 1,159 | 6,510 | 42,879 | 216 | 23,875 | ||
| Fiscal Year - 1 | 2,751 | 1,137 | 6,833 | 42,857 | 219 | 23,890 | ||
| Fiscal Year - 2 | 3,312 | 1,106 | 6,848 | 44,915 | 184 | 26,643 | ||
| Fiscal Year - 3 | 3,828 | 931 | 6,319 | 39,211 | 134 | 24,802 | ||
| Fiscal Year - 4 | 2,663 | 739 | 5,339 | 32,218 | 118 | 22,284 | ||
| Fiscal Year - 5 | 2,884 | 714 | 5,163 | 25,542 | 103 | 17,911 | ||
| Net Income | ||||||||
| Latest Twelve Months | 296 | 132 | 1,259 | 6,514 | (249) | 3,765 | ||
| Fiscal Year | 283 | 168 | 1,289 | 6,335 | (254) | 3,899 | ||
| Fiscal Year - 1 | 180 | 285 | 1,240 | 5,995 | 1 | 4,200 | ||
| Fiscal Year - 2 | 513 | 272 | 1,254 | 6,950 | 2 | 6,222 | ||
| Fiscal Year - 3 | 889 | 140 | 1,210 | 7,725 | 3 | 5,283 | ||
| Fiscal Year - 4 | 631 | 229 | 719 | 6,375 | 2 | 3,510 | ||
| Fiscal Year - 5 | 228 | 96 | 1,071 | 3,696 | 7 | 2,364 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 13,433 | 2,721 | 10,948 | 97,095 | 742 | 83,402 | ||
| Latest Fiscal Quarter | 12,361 | 2,644 | 11,914 | 99,041 | 437 | 79,116 | ||
| Fiscal Year | 12,392 | 2,704 | 11,846 | 97,321 | 447 | 77,542 | ||
| Fiscal Year - 1 | 13,565 | 2,639 | 10,763 | 98,726 | 662 | 84,488 | ||
| Fiscal Year - 2 | 14,130 | 2,295 | 10,532 | 97,154 | 707 | 84,350 | ||
| Fiscal Year - 3 | 15,001 | 2,263 | 10,705 | 95,123 | 601 | 83,184 | ||
| Fiscal Year - 4 | 7,960 | 2,028 | 9,627 | 69,052 | 409 | 76,161 | ||
| Fiscal Year - 5 | 6,539 | 1,884 | 9,452 | 58,381 | 157 | 62,082 | ||
| Fiscal Year - 6 | 5,976 | 1,593 | 8,541 | 56,232 | 164 | 47,833 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 7,846 | 2,014 | 6,188 | 45,516 | 403 | 53,442 | ||
| Latest Fiscal Quarter | 7,637 | 2,018 | 6,027 | 49,390 | 155 | 50,849 | ||
| Fiscal Year | 7,667 | 2,069 | 5,898 | 49,584 | 145 | 49,543 | ||
| Fiscal Year - 1 | 7,873 | 1,967 | 5,845 | 46,735 | 393 | 53,486 | ||
| Fiscal Year - 2 | 7,383 | 1,702 | 5,305 | 43,978 | 394 | 48,414 | ||
| Fiscal Year - 3 | 7,141 | 1,563 | 5,389 | 40,793 | 406 | 41,899 | ||
| Fiscal Year - 4 | 3,735 | 1,381 | 4,873 | 34,507 | 220 | 36,498 | ||
| Fiscal Year - 5 | 2,814 | 1,166 | 4,748 | 29,675 | 111 | 28,671 | ||
| Fiscal Year - 6 | 2,585 | 1,079 | 4,567 | 27,586 | 99 | 28,214 | ||